Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home News Equities

Pepsi Q2 2024 Earnings Summary

by Team Lumida
July 11, 2024
in Equities
Reading Time: 2 mins read
A A
0
blue and red pepsi can

Photo by NIKHIL on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Beats Earnings by ~5% & Misses Revenue expectations by ~0.4%

Total Revenue: $22.5 Bn, up ~1% YoY, up 23% QoQ

Net earnings: $3.03 Bn, up 12% YoY, up 50% QoQ

Shares down ~2% in premarket trading

Key Takeaways:

Consumer preferences shifting towards smaller pack sizes for convenience and price sensitivity impacting volume sales.

Volume declines in Quaker Foods (-18%), Frito-Lay North America (-4%), and North American beverages (-3.5%).

CEO on Company Performance:

“We delivered sequential improvement in volume trends & YoY growth in net revenue, operating profit margin, and EPS – despite certain product recalls at Quaker Foods North America and a difficult net revenue growth comparison from the prior year.”

Tags: $PEPConsumer goodsEARNINGSPackaged Foods and BeveragesPepsiCo
Previous Post

Can Apple’s Vision Pro Bounce Back with a Budget-Friendly Model?

Next Post

Delta Airlines Q2 2024 Earnings Summary

Recommended For You

Shell Maintains $3.5 Billion Buyback Despite Earnings Decline

by Team Lumida
23 hours ago
low angle photography of Shell gas station at night

Key Takeaways: Powered by lumidawealth.com Earnings Decline: Shell’s Q2 adjusted earnings fell 24% to $4.26 billion from $5.58 billion in the previous quarter but beat analyst expectations of $3.74...

Read more

Unilever Beats Q2 Underlying Sales Expectations, Confirms Full-Year Outlook

by Team Lumida
23 hours ago
Unilever Beats Q2 Underlying Sales Expectations, Confirms Full-Year Outlook

Key Takeaways: Powered by lumidawealth.com Sales Growth: Unilever’s underlying sales rose 3.8% in Q2, surpassing analyst expectations of 3.6%, driven by strong demand across all business segments. Turnover Decline:...

Read more

Porsche Cuts 2025 Guidance Again After $1.27 Billion Tariff Hit

by Team Lumida
2 days ago
running black Porsche sedan

Key Takeaways: Powered by lumidawealth.com Tariff Impact: Porsche took a €400 million ($461.9 million) hit from U.S. import tariffs in H1 2025, opting not to pass costs to customers,...

Read more

UBS Posts Strong Q2 Profit as Market Volatility Boosts Trading Revenue

by Team Lumida
2 days ago
UBS Posts Strong Q2 Profit as Market Volatility Boosts Trading Revenue

Key Takeaways: Powered by lumidawealth.com Profit More Than Doubled: UBS reported a Q2 net profit of $2.395 billion, more than doubling from $1.14 billion a year earlier and beating...

Read more

Adidas Shares Drop After Lower-Than-Expected Q2 Sales and Tariff-Related Uncertainty

by Team Lumida
2 days ago
Adidas logo

Key Takeaways: Powered by lumidawealth.com Sales Miss: Adidas reported Q2 sales of €5.95 billion, up 2.2% year-over-year but below analyst expectations of €6.15 billion. Profit Growth: Net profit rose...

Read more

AstraZeneca Reports Strong Q2 Sales and Profit Boosted by Cancer Drugs

by Team Lumida
3 days ago
AstraZeneca Reports Strong Q2 Sales and Profit Boosted by Cancer Drugs

Key Takeaways: Powered by lumidawealth.com Revenue Growth: AstraZeneca’s Q2 revenue rose 12% to $14.5 billion, surpassing analyst estimates. Earnings: Adjusted earnings per share increased 10% to $2.17, in line...

Read more

Whirlpool Cuts Dividend and Lowers Full-Year Profit Guidance Amid Tariff Pressures

by Team Lumida
3 days ago
Whirlpool Cuts Dividend and Lowers Full-Year Profit Guidance Amid Tariff Pressures

Key Takeaways: Powered by lumidawealth.com Profit Outlook Slashed: Whirlpool lowered its full-year adjusted earnings per share (EPS) guidance to $6-$8 from $10, missing analyst expectations of $8.96. Dividend Cut:...

Read more

Boston Beer Cuts Tariff Impact Estimate as Q2 Profit Rises Despite Volume Decline

by Team Lumida
4 days ago
Boston Beer Cuts Tariff Impact Estimate as Q2 Profit Rises Despite Volume Decline

Key Takeaways: Reduced Tariff Impact: Boston Beer lowered its full-year tariff cost estimate to $15-20 million ($0.96-$1.28 per share) from the previous $20-30 million range, citing more moderate...

Read more

Volkswagen Cuts Outlook After $1.5 Billion Tariff Hit

by Team Lumida
7 days ago
blue and white round b logo

Key Takeaways: Powered by lumidawealth.com Tariff Impact: Volkswagen incurred €1.3 billion $1.5 billion in tariff costs in H1 2025, mainly from new U.S. import duties, forcing the company to...

Read more

Carrefour Shares Jump on Sale of Loss-Making Italian Unit

by Team Lumida
7 days ago
Carrefour Shares Jump on Sale of Loss-Making Italian Unit

Key Takeaways: Powered by lumidawealth.com Strategic Exit: Carrefour is selling its loss-making Italian business to NewPrinces Group, taking a €240 million hit but freeing up resources to focus on...

Read more
Next Post
Delta Airlines Q2 2024 Earnings Summary

Delta Airlines Q2 2024 Earnings Summary

Con Agra Brands Q4 2024 Earnings Summary

Con Agra Brands Q4 2024 Earnings Summary

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

China’s Bold Economic Moves: What You Need to Know Now

Chinese Exporters Struggle to Replace U.S. Buyers Amid Tariff Pressures

March 28, 2025
black flat screen tv turned on displaying 11

Netflix Binge-Watching Linked to Shorter Lifespan: Here’s How to Mitigate the Risk

June 17, 2024
China’s AI Startups Challenge Global Leaders Amid U.S. Trade Curbs

Senate Strikes Down Provision Limiting State AI Regulation in Trump Tax Bill

July 1, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018